1. Home
  2. XPOF vs ZNTL Comparison

XPOF vs ZNTL Comparison

Compare XPOF & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xponential Fitness Inc.

XPOF

Xponential Fitness Inc.

HOLD

Current Price

$8.18

Market Cap

207.5M

ML Signal

HOLD

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

HOLD

Current Price

$1.34

Market Cap

118.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPOF
ZNTL
Founded
2017
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.5M
118.3M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
XPOF
ZNTL
Price
$8.18
$1.34
Analyst Decision
Buy
Buy
Analyst Count
8
6
Target Price
$11.69
$5.87
AVG Volume (30 Days)
559.0K
788.0K
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$315,135,000.00
$26,865,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.38
$1.01
52 Week High
$18.87
$3.33

Technical Indicators

Market Signals
Indicator
XPOF
ZNTL
Relative Strength Index (RSI) 59.25 43.17
Support Level $7.27 $1.32
Resistance Level $7.92 $1.46
Average True Range (ATR) 0.38 0.06
MACD 0.04 -0.00
Stochastic Oscillator 59.87 14.71

Price Performance

Historical Comparison
XPOF
ZNTL

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Share on Social Networks: